Skip to main content

Colistin Resistant ABC clinical trials at UC Health

1 in progress, 0 open to eligible people

Showing trials for
  • Study of Experimental Sulbactam-ETX2514 Infections Caused by Acinetobacter baumannii-calcoaceticus Complex

    Sorry, not currently recruiting here

    This is a 2-part study, with Part A being the randomized, controlled portion of the study in patients with ABC (Acinetobacter baumannii-calcoaceticus Complex) hospital-acquired bacterial pneumonia (HABP), ventilator-associated bacterial pneumonia (VABP), or bacteremia. Part B is the single-group portion of the study and includes ABC infections that are resistant to or have failed colistin treatment.

    at UC Davis

Last updated: